Growth Metrics

Bioadaptives (BDPT) Beginning Cash Balance (2021 - 2023)

Bioadaptives' Beginning Cash Balance history spans 3 years, with the latest figure at $50000.0 for Q3 2023.

  • On a quarterly basis, Beginning Cash Balance changed N/A to $50000.0 in Q3 2023 year-over-year; TTM through Dec 2024 was $50000.0, a 0.0% change, with the full-year FY2023 number at $50000.0, up 2980.71% from a year prior.
  • Beginning Cash Balance hit $50000.0 in Q3 2023 for Bioadaptives, up from $1623.0 in the prior quarter.
  • Over the last five years, Beginning Cash Balance for BDPT hit a ceiling of $50000.0 in Q3 2023 and a floor of $1623.0 in Q1 2021.
  • Historically, Beginning Cash Balance has averaged $17748.7 across 3 years, with a median of $1623.0 in 2021.
  • The widest YoY moves for Beginning Cash Balance: up 0.0% in 2022, down 0.0% in 2022.
  • Tracing BDPT's Beginning Cash Balance over 3 years: stood at $1623.0 in 2021, then changed by 0.0% to $1623.0 in 2022, then soared by 2980.71% to $50000.0 in 2023.
  • Business Quant data shows Beginning Cash Balance for BDPT at $50000.0 in Q3 2023, $1623.0 in Q1 2022, and $1623.0 in Q1 2021.